DRUG · Mapped RxNorm record
metformin hydrochloride
Normalized identity: metformin hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
NCT01666171
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
clinical observation
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
diagnostic laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
imaging biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
medical chart review
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
digital mammography
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
metformin hydrochlorideDRUG · verified · RxNorm: metformin hydrochloride
clinical observationOTHER
medical chart reviewOTHER
digital mammographyPROCEDURE
Sponsors & collaborators
Cancer and Leukemia Group Blead sponsor
National Cancer Institute (NCI)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01666171 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.